REGN vs SON · P/E 14, rev $14.34B vs P/E 57, rev $1.36B
Regeneron Pharmaceuticals Inc (REGN) versus Sonoco Products Company (SON) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Sonoco Products Company (SON) is a packaging & containers company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SON revenue for 2024-12-31 was $1.36B. Net income was $163.9M. Revenue was up 0.6% from 2024-09-29 to 2024-12-31. SON currently screens at market cap $4.59B and trailing P/E 56.7.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SON currently screens at market cap $4.59B and trailing P/E 56.7.
Not investment advice. Open the REGN and SON stock pages for the full models.
Not investment advice.